Resources from the same session
5353 - Copanlisib monotherapy activity in relapsed or refractory indolent B-cell lymphoma: combined analysis from phase I and II studies
Presenter: Martin Dreyling
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
3282 - Final Overall Survival Results of Frontline Bortezomib plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (VR-CAP) vs R-CHOP in Transplantation-ineligible Patients (Pts) with Newly Diagnosed Mantle-Cell Lymphoma (MCL): A Randomized, Open-Label, Phase 3 (LYM-3002) Study
Presenter: Michele Ghielmini
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
2495 - A Revised International Prognostic Score System for Waldenström’s Macroglobulinemia
Presenter: MARIA GAVRIATOPOULOU
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
2506 - Impact of initial treatment (tx) on HRQoL and outcomes in patients (pts) with newly diagnosed multiple myeloma (NDMM) without intent for immediate transplant (SCT): Results from the Connect® MM registry
Presenter: Rafat Abonour
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
Proffered paper session - Haematological malignancies - Invited Discussant 1007O
Presenter: Maria-Victoria Mateos
Session: Proffered paper session - Haematological malignancies
Resources:
Slides
Webcast